Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stergios A. Polyzos, Aristotle University Of Thessaloniki
ClinicalTrials.gov Identifier:
NCT01147523
First received: June 17, 2010
Last updated: January 19, 2012
Last verified: January 2012